Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Sernova (SVA) Stock Price & Analysis

SVA Stock Chart & Stats

CA$0.11CA$0.00(0.00%)
At close: 11:29 AM EST
C$0.1C$0.12C$0.1410 Aug24 Aug8 Sep21 Sep5 Oct19 Oct2 Nov
Day’s Range
CAD 0.10 - CAD 0.11
52-Week Range
CAD 0.09 - CAD 0.20
Previous Close
CAD 0.11
Volume
N/A
Average Volume (3M)
172.70K
Market Cap
CAD 39.65M
Enterprise Value
CAD 56.09M
Total Cash (Recent Filing)
CAD 63.33K
Total Debt (Recent Filing)
CAD 2.58M
Price to Earnings (P/E)
―
Beta
0.07
Next Earnings
Mar 12, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Reusable Cell-Therapy Platform

The Cell Pouch System offers a potentially reusable implant platform across chronic-disease applications, including insulin-dependent diabetes. If clinical development succeeds, a scalable platform could support multiple programs and create durable strategic value beyond a single therapy.

Improving Loss Trend

The substantial reduction in net losses indicates a lower spending profile or meaningful cost control relative to prior periods. Although profitability remains distant, continued improvement could extend development runway and reduce the pace at which external capital is required.

Lower Cash-Burn Run Rate

Operating cash outflows have declined materially from 2023 and 2024 levels, suggesting improved spending discipline or a narrower development footprint. A lower burn rate can preserve resources for priority clinical work and make future financing needs more manageable.

Bears Say

No Commercial Revenue

With no reported revenue base, Sernova has not yet demonstrated commercial traction or internally funded operations. Its financial outlook remains dependent on clinical progress, regulatory approval, and eventual commercialization of its therapies or platform.

Negative Shareholders’ Equity

Negative shareholders’ equity signals accumulated financial pressure and leaves the company with limited balance-sheet resilience. This weak capital position can constrain strategic flexibility and increase dependence on future financing or other forms of external support.

Persistent External-Funding Dependence

Persistently negative operating and free cash flow show that development activities are not funded by operations. Sernova therefore remains reliant on equity financing, grants, or strategic arrangements, creating ongoing funding execution and potential dilution pressure.

Sernova News

SVA FAQ

What was Sernova’s price range in the past 12 months?
Sernova lowest stock price was C$0.09 and its highest was C$0.20 in the past 12 months.
What is Sernova’s market cap?
Sernova’s market cap is C$39.65M.
When is Sernova’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Sernova’s earnings last quarter?
Sernova released its earnings results on Sep 10, 2026. The company reported -C$0.01 earnings per share for the quarter, missing the consensus estimate of -C$0.007 by -C$0.003.
Is Sernova overvalued?
According to Wall Street analysts Sernova’s price is currently Undervalued.
Does Sernova pay dividends?
Sernova does not currently pay dividends.
What is Sernova’s EPS estimate?
Sernova’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sernova have?
Sernova has 377,642,520 shares outstanding.
What happened to Sernova’s price movement after its last earnings report?
Sernova reported an EPS of -C$0.01 in its last earnings report, missing expectations of -C$0.007. Following the earnings report the stock price went down -3.571%.
Which hedge fund is a major shareholder of Sernova?
Currently, no hedge funds are holding shares in TSE:SVA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology